Marcos González - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Marcos González's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Marcos González
Verified
Founder, Corresponsables España
Beats
Wall Street , Silicon Valley , Investigations
Anything that is not related to food.
Content
Adjuvant chemotherapy in localized, resectable extremity and truncal soft tissue sarcoma and survival outcomes – A systematic review and meta‐analysis of randomized controlled trials
By Megan Goh, Marcos Gonzalez, Marcos González Verified, Hillary M. Heiling, Emanuele Mazzola| Wiley Online Library Verified The role of adjuvant chemotherapy in localized, resectable soft tissue sarcomas (STSs) remains controversial. Despite positive findings reported in previous meta-analyses, the majority of randomized controlled trials (RCTs) fail to show a meaningful benefit.
Aproximación a la marca-patrón desde la teoría de la interacción entre derecho de marcas y diseño industrial
By Marcos Gonzalez, Marcos González Verified, Cruz 'Mickey' Gonzalez| Dialnet - Universidad de La Rioja@ Ayuda Buscar en la ayuda Buscar en la ayuda Aproximación a la marca-patrón desde la teoría de la interacción entre derecho de marcas y diseño industrial [1] Universidad de Salamanca Localización: Actas de derecho industrial y derecho de autor, ISSN 1139-3289, Tomo 44, 2024, págs.
Adjuvant chemotherapy in localized, resectable extremity and truncal soft tissue sarcoma and survival outcomes – A systematic review and meta‐analysis of randomized controlled trials
By Megan Goh, Marcos Gonzalez, Marcos González Verified, Hillary M. Heiling, Emanuele Mazzola| Wiley Online Library Verified The role of adjuvant chemotherapy in localized, resectable soft tissue sarcomas (STSs) remains controversial. Despite positive findings reported in previous meta-analyses, the majority of randomized controlled trials (RCTs) fail to show a meaningful benefit.
Company Info
Corresponsables España